Jinsy Andrews, director of neuromuscular clinical trials at Columbia University Irving Medical Center, discusses the unique challenges faced by researchers working to develop new medications to treat ALS. #ALS #JohnsHopkins [ Ссылка ]

Chapters:
2:44 Choosing ideal drug target
18:45 Developing an ideal clinical endpoint
28:55 Navigating the regulatory landscape
49:30 New legislation to accelerate drug approval

свернуть